PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

18F-fallypride

Single bolus i.v. injection 60 minutes before PET-CT scanning. Maximum activity per single administration 5 mCi; maximum amount of drug per administration \<10 micrograms.

DRUG

18F-fallypride

I.v. bolus maximum activity per single administration 5 mCi; maximum amount of drug per administration \<10 micrograms.

Trial Locations (1)

92868

University of California Irvine Medical Center, Orange

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of California, Irvine

OTHER